跳至主要内容
临床试验/NCT06329479
NCT06329479已完成不适用

The RALI Study: a Multimodal Non-pharmacological (Clinical Review, Physical Activity, Bright Light Therapy and Cognitive Behavioural Therapy for Insomnia) Feasibility Trial for Circadian Rest-activity Rhythm Disorders in Patients With Advanced Cancer

University of Dublin, Trinity College4 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2023年6月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30
试验地点
4
主要终点
Adverse events

研究概览

简要总结

Circadian rest-activity rhythm disorders are common in patients with cancer, particularly in advanced disease. A recent international e-Delphi study has outlined recommendations for the assessment and reporting of the disorder and subsequently an observation study is underway assessing a cohort of patients with advanced cancer. Affected patients are eligible to enter a feasibility study assessing a non-pharmacological multi-modal intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥18 years old
  • Diagnosis of advanced cancer (locally advanced, incurable, metastatic)
  • Estimated prognosis ≥ 3 months
  • Evidence of a circadian rest-activity rhythm disorder

排除标准

  • Engaged in shift-work
  • Long-haul travel in the last 14 days
  • Physical impairment limiting movement of the non-dominant arm
  • Cognitive impairment limiting the ability to complete the assessment tool and/or patient diary
  • Uncontrolled high blood pressure or tachycardia
  • Exercise-related symptoms and signs (e.g. chest pain, syncope, limb claudication, hypoxia at rest)
  • Participant has a history of uncontrolled mania or bipolar disorder
  • Participant has a recent history or current thoughts of self-harm or suicide
  • Participant has a recent change in antidepressant medication
  • Participant has an eye disorder (e.g. glaucoma, cataracts, retinopathy)

结局指标

主要结局

Adverse events

时间窗: Outcome assessed weekly during an 8-week trial

Number of subjects develop adverse events during the trial in accordance with the Common Terminology Criteria for Adverse Events (CTCAE)

Acceptability and usability of a multi-modal non-pharmacological intervention

时间窗: At the end of 8-weeks

Patient completed questionnaire of the acceptability and usability of interventions and research assessments

Completion rates of research assessments

时间窗: Completed at baseline, week 2, week 4 and week 8

Number of participants completing the midpoint and end of study assessments

Adherence to interventions

时间窗: Outcome assessed weekly during the 8-week trial

Patient completed weekly diary of adherence to the interventions and weekly monitoring by the researcher

Recruitment rate

时间窗: 1 year

Number of participants recruited to the feasibility study over a 1 year period

次要结局

  • Symptom assessment(Time 1 (baseline), Time 2 (end of 4 weeks), Time 3 (end of 8 weeks))
  • Physical activity assessment(Continuous midweek 72-hour monitoring at baseline, Continuous midweek 72-hour monitoring during week 7)
  • Daytime Sleepiness(Time 1 (baseline), Time 2 (end of 4 weeks), Time 3 (end of 8 weeks))
  • Physical activity and sleep assessment(Continuous midweek 72-hour monitoring at baseline, Continuous midweek 72-hour monitoring during week 7)
  • Quality of Life assessment(Time 1 (baseline), Time 2 (end of 4 weeks), Time 3 (end of 8 weeks))
  • Sleep Quality(Time 1 (baseline), Time 2 (end of 4 weeks), Time 3 (end of 8 weeks))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof Andrew Davies

Professor of Palliative Medicine

University of Dublin, Trinity College

研究点 (4)

Loading locations...

相似试验